Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1982-08-05
1984-07-03
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 10, 424 16, 424 31, 424 32, 424 36, A61K 930, A61K 3100, A61K 922
Patent
active
044579071
ABSTRACT:
A therapeutic composition comprising a therapeutic drug that can cause undesirable effects on the pre-intestinal phases when contacting these phases, and an enteric coating surrounding the drug. A method for protecting a therapeutic drug including forming an enteric coating around the drug.
REFERENCES:
patent: 874310 (1907-12-01), Donard et al.
patent: 1335488 (1920-03-01), Davis
patent: 2657972 (1953-11-01), Woodward
patent: 2687367 (1954-08-01), Burrin
patent: 2921001 (1960-01-01), McDermott
patent: 2957804 (1960-10-01), Shuyler
patent: 2996431 (1961-08-01), Barry
patent: 3351531 (1967-11-01), Noznick et al.
patent: 3629390 (1971-12-01), Wentworth
patent: 3639565 (1972-02-01), Prillig
patent: 3867520 (1975-02-01), Mori et al.
patent: 4175119 (1979-11-01), Porter
patent: 4230687 (1980-10-01), Sair et al.
patent: 4291016 (1981-09-01), Nougaret
patent: 4351337 (1982-09-01), Sidman
Hermandez et al., Chem. Abstracts 93 #199677z (1980) of Biopolymers (1980) 19(10); 1715-1721.
Kamei et al., Chem. Abstracts 87 #17676u (1977) of Chem. Pharm. Bull. (1976) 24(11): 2619-2623.
Rolfing et al., Chem. Abstracts 78 #148227k (1973) of Mol. Evol., 1972: 219-231.
Hennon et al., Chem. Abstracts 75 #64245g (1975) of Biochemie 1971 53(2): 215-223.
Clear Lake Development Group
Rose Shep K.
LandOfFree
Composition and method for protecting a therapeutic drug does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for protecting a therapeutic drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for protecting a therapeutic drug will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1630082